![chinabased keep linkdoc us ipotimes chinabased keep linkdoc us ipotimes](https://www.weekinchina.com/app/uploads/2021/04/Forest-Huang-w-355x355.jpg)
It thus became the first prominent Chinese company to halt its US IPO plans after Beijing cracked down on domestic companies listing overseas. Their first quarter revenue for this year was RMB 223 million yuan, up by RMB 159 million yuan from the same period of 2020.īut in July, LinkDoc scrapped plans to list due to market volatility. Since the beginning of 2021, Keep has been IPO many times. SEE ALSO: LinkDoc to List on NASDAQ, Sets Sights on $1.5 Billion Market ValueĪccording to the prospectus disclosed by the company itself, the company’s revenue in 20 were RMB 374 million yuan and RMB 942 million yuan respectively, with a year-on-year increase of 89%. By Will Feuer China-based medical data company LinkDoc Technology Ltd. At that time, it was set to raise as much as $211 million from issuing $10.8 million shares at a price of $17.50 to $19.50. Sources: after the Didi crackdown, China-based fitness app Keep, podcasting platform Ximalaya, medical data analytics startup LinkDoc pause their US IPO plans (Financial Times) Close. In June this year, LinkDoc officially submitted its prospectus to the US Securities and Exchange Commission (SEC) and planned to list on the Nasdaq. The service will work by connecting APPs such as the Ali Health platform with the LinkDoc Internet Hospital and Cancer Patient Service Center.
![chinabased keep linkdoc us ipotimes chinabased keep linkdoc us ipotimes](https://www.inquirer.com/resizer/qGeVCSbPztz6fVBqU7mr32SS3j8=/700x467/smart/filters:format(webp)/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/7AJIMFYYFJGMBCWJ6OEJYKX65U.jpg)
IPO as the fallout from China’s crackdown on data-rich companies listing overseas continues. The two sides announced that they will build a patient-centered and innovation-driven service platform, which provides whole-cycle support for cancer patients. Alibaba-backed medical data firm LinkDoc Technology Ltd. The company was looking to raise as much as 211 million in the share sale. initial public offering following China’s crackdown on overseas listings by local firms, Reuters reported, citing unidentified people. In March this year, Alibaba Health made a strategic investment in the company. (Bloomberg) - LinkDoc Technology, a Beijing-based medical data company, has shelved plans for a U.S. Since 2015, the company has completed five rounds of financing with investors such as Alibaba Health, Youshan Capital, CBC Capital, Ally Bridge Group and others.
![chinabased keep linkdoc us ipotimes chinabased keep linkdoc us ipotimes](https://cornerstonefocusinvestments.files.wordpress.com/2019/07/r2k-perf-190630.png)
They added that the specific plan and details of the Pre-IPO and the Hong Kong IPO could still change.įounded in 2014, LinkDoc specializes in providing big data and artificial intelligence solutions for all parties in the pharmaceutical and medical industries. Chinese medical data group LinkDoc Technology Ltd (LDOC.O) has shelved plans for an IPO in the United States. According to Bloomberg, LinkDoc Technology Limited, a medical data platform company backed by Alibaba Group, plans to lead a $200 to $300 million financing round before its upcoming IPO in Hong Kong.Ī person familiar with the matter said such a plan is still under discussion and no decision has been made yet.